ETF Holdings Breakdown of TMCI

Stock Name	Treace Medical Concepts Inc
Ticker	TMCI(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US89455T1097

TMCI institutional holdings

The following institutional investment holdings of TMCI have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-27 IE00BMX0DF60 (iShares US Medical Devices UCITS ETF) 6,245 USD 42,778

Total = 6,245 USD 42,778
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-27	IE00BMX0DF60 (iShares US Medical Devices UCITS ETF)	6,245	USD 42,778
Total =	6,245	USD 42,778

News associated with TMCI

Head-To-Head Survey: Treace Medical Concepts (NASDAQ:TMCI) versus Nihon Kohden (OTCMKTS:NHNKY): Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) and Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Risk and Volatility Nihon Kohden has […] - 2025-08-31 05:50:53
Stifel Nicolaus Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00: Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its price objective cut by Stifel Nicolaus from $9.00 to $6.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a hold rating on the stock. Other equities analysts have also issued reports about the company. UBS Group reduced their price target […] - 2025-08-11 03:42:56
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $10.52: Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are currently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target […] - 2025-08-04 02:26:49
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $10.16: Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) have earned a consensus rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year […] - 2025-07-10 02:34:50
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of “Hold” by Analysts: Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) has earned a consensus rating of “Hold” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year target price among […] - 2025-06-12 04:56:54
Squarepoint Ops LLC Sells 52,890 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI): Squarepoint Ops LLC lowered its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 74.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 18,470 shares of the company’s stock after selling 52,890 shares during the quarter. Squarepoint Ops LLC’s holdings in Treace Medical Concepts were worth $137,000 as of […] - 2025-06-10 04:25:03
Two Sigma Investments LP Sells 7,346 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI): Two Sigma Investments LP decreased its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 153,824 shares of the company’s stock after selling 7,346 shares during the period. Two Sigma […] - 2025-06-05 04:44:59
13,739 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by ProShare Advisors LLC: ProShare Advisors LLC bought a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm bought 13,739 shares of the company’s stock, valued at approximately $102,000. Several other institutional investors have also recently made changes to their positions in the business. MIRAE ASSET […] - 2025-06-04 04:40:51
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $10.16: Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) has received an average rating of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target […] - 2025-05-21 03:14:50
Balyasny Asset Management L.P. Sells 189,380 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI): Balyasny Asset Management L.P. reduced its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 94.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,723 shares of the company’s stock after selling 189,380 shares during the period. Balyasny […] - 2025-05-19 04:52:49
Wells Fargo & Company MN Raises Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI): Wells Fargo & Company MN boosted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 45.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 24,796 shares of the company’s stock after acquiring an additional 7,769 shares during […] - 2025-05-09 04:18:47
Stifel Financial Corp Buys 55,540 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI): Stifel Financial Corp lifted its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 41.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 189,301 shares of the company’s stock after acquiring an additional 55,540 shares during the period. […] - 2025-05-08 05:16:52
Marshall Wace LLP Has $661,000 Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI): Marshall Wace LLP decreased its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 79.2% during the 4th quarter, HoldingsChannel reports. The fund owned 88,910 shares of the company’s stock after selling 337,820 shares during the period. Marshall Wace LLP’s holdings in Treace Medical Concepts were worth $661,000 as of its most recent […] - 2025-05-02 05:32:47
Legal & General Group Plc Sells 36,793 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI): Legal & General Group Plc trimmed its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 87.2% during the 4th quarter, Holdings Channel reports. The firm owned 5,423 shares of the company’s stock after selling 36,793 shares during the quarter. Legal & General Group Plc’s holdings in Treace Medical Concepts were worth $40,000 […] - 2025-05-02 04:40:55
Vanguard Group Inc. Has $20.33 Million Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI): Vanguard Group Inc. lowered its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 0.3% during the fourth quarter, Holdings Channel reports. The fund owned 2,732,585 shares of the company’s stock after selling 8,903 shares during the quarter. Vanguard Group Inc.’s holdings in Treace Medical Concepts were worth $20,330,000 at the […] - 2025-04-16 04:28:49
ExodusPoint Capital Management LP Invests $251,000 in Treace Medical Concepts, Inc. (NASDAQ:TMCI): ExodusPoint Capital Management LP bought a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 33,721 shares of the company’s stock, valued at approximately $251,000. ExodusPoint Capital Management LP owned […] - 2025-04-14 05:27:05
Truist Financial Issues Pessimistic Forecast for Treace Medical Concepts (NASDAQ:TMCI) Stock Price: Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its price target lowered by Truist Financial from $9.50 to $8.00 in a report released on Friday,Benzinga reports. The firm currently has a hold rating on the stock. A number of other equities research analysts have also issued reports on TMCI. Lake Street Capital initiated coverage on […] - 2025-04-14 02:44:52
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Average PT from Brokerages: Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) have received a consensus rating of “Hold” from the seven research firms that are currently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 […] - 2025-04-01 02:24:58
Bank of New York Mellon Corp Has $937,000 Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI): Bank of New York Mellon Corp boosted its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) by 2.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 125,945 shares of the company’s stock after acquiring an additional 3,215 shares during the period. Bank of New York Mellon Corp’s holdings in […] - 2025-03-26 05:10:45
Connor Clark & Lunn Investment Management Ltd. Takes $342,000 Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI): Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 45,923 shares of the company’s stock, valued at approximately $342,000. A number of other large investors […] - 2025-03-24 05:56:54

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.